Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1L. Képénékian, P. Combemale, Thomas Mognetti et al.|European Journal of Endocrinology|2016Cited by 69
Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1P. Combemale, Thomas Mognetti, L. Valeyrie‐Allanore et al.|PLoS ONE|2014Cited by 60
Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 PatientsMehdi Brahmi, P. Combemale, Philippe Thiesse et al.|PLoS ONE|2015Cited by 52
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancerPierre-Étienne Heudel, Jean-Luc Soubirou, H. Boyle et al.|ESMO Open|2021Cited by 35
Intérêt de la tomographie par émission de positons au fluorodéoxyglucose 18 dans la détection des neurofibrosarcomes au cours de la neurofibromatose de type 1B. Bensaïd, P. Combemale, Francesco Giammarile et al.|Annales de Dermatologie et de Vénéréologie|2007Cited by 23